Online Research Seminars
June 4 - 11 a.m.
Mala Maini, M.D., University College, London
"Immunobiology of Chronic Hepatitis B"
To register for this seminar, please click here.
Dr. Maini is a professor of viral immunology in the division of infection and immunity at UCL, London and also works as a consultant physician in a viral hepatitis clinic. Her lab researches liver immunity and immunopathology, focusing on cellular interactions and metabolic constraints in the liver. Work from the Maini lab aims to contribute to the development of novel immunotherapeutic strategies for hepatitis B and hepatocellular carcinoma.
June 18 - 11 a.m.
Scott L. Friedman, M.D., Ichan School of Medicine, N.Y.C.
"Molecular Biology and Medicine of Liver Fibrosis"
Dr. Friedman is the dean for therapeutic discovery and chief of the Division of Liver Diseases at the Icahn School of Medicine at Mount Sinai. He has performed pioneering research into the underlying causes of scarring, or fibrosis associated with chronic liver disease, affecting millions worldwide. Dr. Friedman was among the first to isolate and characterize the hepatic stellate cell, the key cell type responsible for scar production in liver. His work has spawned an entire field that is now realizing its translational and therapeutic potential, with new anti-fibrotic therapies for liver disease reaching clinical trials.
June 30 - 11 a.m.
Marion Peters, M.D., University of California, San Francisco
Bruce Witte Distinguished Lecture, "Precision Medicine for Chronic Hepatitis B"
Dr. Peters works in the NIH AIDS Clinical Trials Group (ACTG) Hepatitis Transformative Science Group (TSG) where she has the been a driving force in the development of US and international studies for new drugs for patients with HBV, with and without HIV. She is an Emeritus Professor of Medicine at the University of California at San Francisco and Adjunct Professor of Medicine at Northwestern University. She received her Bachelor of Medicine/Bachelor of Surgery degree and her Doctorate of Medicine from Melbourne University Medical School in Melbourne, Australia. She is a hepatologist with a particular interest in viral hepatitis. Her research focuses on viral hepatitis in complicated clinical settings, patients with co-morbid conditions including alcoholism and HIV infection. She has numerous publications on viral hepatitis with and without HIV coinfection in peer-reviewed journals with multiple collaborators. You can read more about Dr. Peters here and here.
Date and time TBD
Rohit Loomba, M.D., University of California, San Diego
"Reactivation of Hepatitis B"